New patent for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent for Boehringer Ingelheim drug TRIJARDY XR appea…
New patent for Boehringer Ingelheim drug TRIJARDY XR Read Post »